| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO | President &CEO +1 more
2 companies
Mattessich Antony C. is a President And CEO at OCUL, with reported holdings spanning 2 companies. Recent filings cover 6 purchases and 3 sales. Those positions are worth an estimated $2.9M at current prices.
Our model assigns Mattessich Antony C. a below-average insider score of 47/100, based on 5 past trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -16.9%.
Mattessich Antony C.'s largest disclosed position is in OCUL as President And CEO, worth about $2.9M. Net of sales, the recent Form 4 record there shows accumulation of 51,751 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | OCUL Ocular Therapeutix, Inc | President And CEO | Sell | 19,642 | $4.86 | $95,460.12 | -3.2% | +17.2% | +58.0% | |
| Jan 31, 2024 | OCUL Ocular Therapeutix, Inc | President And CEO | Sell | 18,338 | $4.95 | $90,773.10 | -4.1% | -2.5% | +60.1% | |
| Aug 30, 2023 | OCUL Ocular Therapeutix, Inc | President And CEO | Buy | 6,500 | $3.81 | $24,765.00 | New | -40.5% | +122.3% | |
| Feb 6, 2023 | OCUL Ocular Therapeutix, Inc | President And CEO | Sell | 19,669 | $4.24 | $83,396.56 | -4.2% | +50.6% | +18.6% | |
| Aug 20, 2021 | OCUL Ocular Therapeutix, Inc | President And CEO | Buy | 5,000 | $9.89 | $49,450.00 | +5.1% | -33.0% | -47.8% | |
| Jun 6, 2019 | OCUL Ocular Therapeutix, Inc | President &CEO | Buy | 40,000 | $2.81 | $112,400.00 | +69.1% | - | - | |
| Aug 20, 2018 | OCUL Ocular Therapeutix, Inc | President &CEO | Buy | 20,000 | $5.95 | $119,000.00 | +52.8% | - | - | |
| Aug 10, 2018 | OCUL Ocular Therapeutix, Inc | President And CEO | Buy | 16,900 | $6.23 | $105,287.00 | +80.5% | - | - | |
| Dec 12, 2017 | OCUL Ocular Therapeutix, Inc | President And C.e.o. | Buy | 21,000 | $4.29 | $90,090.00 | New | - | - |